scispace - formally typeset
J

Jesus Esquivel

Researcher at St. Agnes Hospital

Publications -  68
Citations -  3568

Jesus Esquivel is an academic researcher from St. Agnes Hospital. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Colorectal cancer. The author has an hindex of 28, co-authored 64 publications receiving 3237 citations. Previous affiliations of Jesus Esquivel include Washington Cancer Institute & Cancer Treatment Centers of America.

Papers
More filters
Journal ArticleDOI

Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique

TL;DR: HIIC may be applied to select patients with peritoneal carcinomatosis from gastrointestinal malignancies with 27.0% major morbidity and 1.5% treatment-related mortality.
Journal ArticleDOI

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

Jesus Esquivel, +74 more
TL;DR: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin : a consensus statement.
Journal ArticleDOI

Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy

TL;DR: The mortality of 2.0% and the overall grade IV morbidity of 19% in these patients may be acceptable in light of modern standards for the management of gastrointestinal cancer.
Journal ArticleDOI

Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

TL;DR: This manuscript will analyze and discuss the results of a group of health care providers trying to achieve a consensus statement in the management of this group of patients.
Journal ArticleDOI

Clinical presentation of the Pseudomyxoma peritonei syndrome.

TL;DR: The aim was to analyse the presenting symptoms and signs of patients with Pseudomyxoma peritonei syndrome.